SMT Celebrates 20 Years of the Cocoon Occluder Journey, Transforming Lives in Congenital and Structural Heart Defects
Nov 11, 2025
Mumbai (Maharashtra) [India], November 11: Congenital Heart Disease (CHD) is one of the most common birth defects, affecting approximately 1% of live births globally and accounting for more than 4.18 million cases in children under five1. Despite advances in medical care, CHD continues to be a leading cause of infant and child mortality, highlighting the need for safe and minimally invasive treatment options. Commonly identified congenital heart defects include atrial septal defect (ASD), patent ductus arteriosus (PDA), and ventricular septal defect (VSD). Additionally, structural heart defects like patent foramen ovale (PFO) is also a common defect impacting approximately 25% adults globally2. These defects are typically treated using occluders, which are catheter-based devices designed to close abnormal openings in the heart.
Read More ..